scholarly journals International Adverse Selection in Life Insurance and Annuities

2003 ◽  
Author(s):  
Olivia S. Mitchell ◽  
David McCarthy
2004 ◽  
Author(s):  
Mattias K. Polborn ◽  
Michael Hoy ◽  
Asha Sadanand

1992 ◽  
Vol 7 (2) ◽  
pp. 241-249 ◽  
Author(s):  
Elazar Berkovitch ◽  
Itzhak Venezia

This paper attempts to explain why individuals may purchase whole life insurance even when term (short period) insurance seems to be less expensive. Under a whole life insurance contract (referred to also as straight life insurance) the insured pays the same rates over his or her lifetime although his or her future health may change. Individuals whose health has deteriorated (relative to their age) over time are more likely to hold on to their contracts than individuals whose health has improved (relative to their age) and who may find it profitable to break their contract and purchase a new one. The insurer, recognizing this adverse selection problem, must set its price for the initial period (and thus for the entire life of the insured) so that it compensates for the above-mentioned adverse selection. The insurer will hence set the price (rate) of whole life insurance higher than the rate of term insurance, since the latter form of insurance is not susceptible to future adverse selection. Assuming the competition between insurers drives their profits to zero (i.e., assuming they provide fair premiums), it is shown that the equilibrium price of whole life insurance is higher than for term insurance. The insured, however, will purchase only whole life insurance, since the additional insurance which the whole life contract provides on the stochastic future insurance rates is priced fairly, and a rational risk-averse insured will always prefer purchasing such insurance.


2022 ◽  
Author(s):  
Timothy F. Harris ◽  
Aaron Yelowitz ◽  
Jeffery Talbert ◽  
Alison Davis

1999 ◽  
Vol 66 (4) ◽  
pp. 531 ◽  
Author(s):  
Krupa Subramanian ◽  
Jean Lemaire ◽  
John C. Hershey ◽  
Mark V. Pauly ◽  
Katrina Armstrong ◽  
...  

1997 ◽  
Vol 352 (1357) ◽  
pp. 1063-1066 ◽  
Author(s):  
P. S. Harper

Life insurance is a key element of the UK social structure in terms of family protection and house purchase; it thus needs to be viewed in this broad context, rather that solely as a commercial activity. Insurers have not so far actively requested genetic tests for life insurance, but have insisted on knowing of and being able to act on existing genetic test information. The main reason given for this has been to avoid servious adverse selection; however, this has never been adequately estimated. Review of the different major categories of Medelian genetic disorders suggests that the scope for adverse selection is extremely limited and that insurers would lose little, and possibly gain more, by foregoing the disclosure and use of this information in relation to life insurance policies of ‘normal’ size and nature. The likely future use in service of genetic tests based on susceptibility or population screening makes it especially important that the issue is rapidly resolved for Menelian disorders; so far there is no sign that insurers are willing to achieve this.


2007 ◽  
Vol 74 (1) ◽  
pp. 65-86 ◽  
Author(s):  
Krupa S. Viswanathan ◽  
Jean Lemaire ◽  
Kate Withers ◽  
Katrina Armstrong ◽  
Agnieszka Baumritter ◽  
...  

2015 ◽  
Vol 54 (1) ◽  
pp. 450-463 ◽  
Author(s):  
David Hedengren ◽  
Thomas Stratmann

2007 ◽  
pp. 57-70
Author(s):  
Ken R. Smith ◽  
Cathleen D. Zick ◽  
Robert N. Mayer ◽  
Jeffrey R. Botkin

Sign in / Sign up

Export Citation Format

Share Document